These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11704167)

  • 1. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial.
    Miller L; Notter KM
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):771-8. PubMed ID: 11704167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M; Røde A; Westergaard J
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial.
    Miller L; Hughes JP
    Obstet Gynecol; 2003 Apr; 101(4):653-61. PubMed ID: 12681866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.
    Edelman AB; Gallo MF; Jensen JT; Nichols MD; Schulz KF; Grimes DA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004695. PubMed ID: 16034942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen.
    Sulak PJ; Kuehl TJ; Coffee A; Willis S
    Am J Obstet Gynecol; 2006 Oct; 195(4):935-41. PubMed ID: 16647684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
    Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
    Seidman DS; Yeshaya A; Ber A; Amodai I; Feinstein I; Finkel I; Gordon N; Porat N; Samuel D; Shiran-Makler E; Wolman I
    Isr Med Assoc J; 2010 Jul; 12(7):400-5. PubMed ID: 20862819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial.
    Anderson FD; Gibbons W; Portman D
    Am J Obstet Gynecol; 2006 Jul; 195(1):92-6. PubMed ID: 16813747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized study of an extended cycle oral contraceptive.
    Anderson FD; Hait H
    Contraception; 2003 Aug; 68(2):89-96. PubMed ID: 12954519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conception control by vaginal administration of pills containing ethinyl estradiol and dl-norgestrel.
    Coutinho EM; da Silva AR; Carreira C; Rodrigues V; Gonçalves MT
    Fertil Steril; 1984 Sep; 42(3):478-81. PubMed ID: 6381103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization.
    Hampton RM; Fisher AC; Pagano S; LaGuardia KD
    Fertil Steril; 2009 Aug; 92(2):434-40. PubMed ID: 18930189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen.
    Coffee AL; Sulak PJ; Kuehl TJ
    Contraception; 2007 Jun; 75(6):444-9. PubMed ID: 17519150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol.
    Anderson FD; Gibbons W; Portman D
    Contraception; 2006 Mar; 73(3):229-34. PubMed ID: 16472561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
    Sinofsky FE; Pasquale SA
    Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H
    Acta Obstet Gynecol Scand; 1988; 67(2):171-4. PubMed ID: 2972160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
    Schwarz BE; Pierce C; Walden CE; Knopp RH
    Int J Fertil; 1992; 37(3):176-82. PubMed ID: 1355765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.
    Westhoff C; Osborne LM; Schafer JE; Morroni C
    Obstet Gynecol; 2005 Jul; 106(1):89-96. PubMed ID: 15994622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.